McCaskill Demands Explanation for Nostrum’s August Price Hikes

Sen. Claire McCaskill (D-Mo.) called on Nostrum Pharmaceuticals, a drugmaker with facilities in Kansas City, to explain a reported 400 percent price hike in its bladder infection treatment, nitrofurantoin.
Source: Drug Industry Daily